139 related articles for article (PubMed ID: 18479899)
1. Soy protein hydrolysate ameliorates cardiovascular remodeling in rats with L-NAME-induced hypertension.
Yang HY; Yang SC; Chen ST; Chen JR
J Nutr Biochem; 2008 Dec; 19(12):833-9. PubMed ID: 18479899
[TBL] [Abstract][Full Text] [Related]
2. Renoprotective effects of soy protein hydrolysates in N(omega)-nitro-L-arginine methyl ester hydrochloride-induced hypertensive rats.
Yang HY; Chen JR
Hypertens Res; 2008 Jul; 31(7):1477-83. PubMed ID: 18957819
[TBL] [Abstract][Full Text] [Related]
3. Effects of soy protein hydrolysate on blood pressure and angiotensin-converting enzyme activity in rats with chronic renal failure.
Yang HY; Chen JR; Chang LS
Hypertens Res; 2008 May; 31(5):957-63. PubMed ID: 18712051
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis.
Katoh M; Egashira K; Mitsui T; Chishima S; Takeshita A; Narita H
J Mol Cell Cardiol; 2000 Jan; 32(1):73-83. PubMed ID: 10652192
[TBL] [Abstract][Full Text] [Related]
5. Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney.
Bernátová I; Pechánová O; Simko F
Exp Physiol; 1999 Nov; 84(6):1095-105. PubMed ID: 10564706
[TBL] [Abstract][Full Text] [Related]
6. Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.
Bernátová I; Pechánová O; Pelouch V; Simko F
J Mol Cell Cardiol; 2000 Feb; 32(2):177-85. PubMed ID: 10722795
[TBL] [Abstract][Full Text] [Related]
7. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone.
Paulis L; Matuskova J; Adamcova M; Pelouch V; Simko J; Krajcirovicova K; Potacova A; Hulin I; Janega P; Pechanova O; Simko F
Acta Physiol (Oxf); 2008 Sep; 194(1):45-55. PubMed ID: 18419778
[TBL] [Abstract][Full Text] [Related]
8. L-arginine fails to protect against myocardial remodelling in L-NAME-induced hypertension.
Simko F; Luptak I; Matuskova J; Krajcirovicova K; Sumbalova Z; Kucharska J; Gvozdjakova A; Simko J; Babal P; Pechanova O; Bernatova I
Eur J Clin Invest; 2005 Jun; 35(6):362-8. PubMed ID: 15948896
[TBL] [Abstract][Full Text] [Related]
9. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
[TBL] [Abstract][Full Text] [Related]
10. Novel diallyldisulfide analogs ameliorate cardiovascular remodeling in rats with L-NAME-induced hypertension.
Sharma DK; Manral A; Saini V; Singh A; Srinivasan BP; Tiwari M
Eur J Pharmacol; 2012 Sep; 691(1-3):198-208. PubMed ID: 22819707
[TBL] [Abstract][Full Text] [Related]
11. Asiatic acid alleviates cardiovascular remodelling in rats with L-NAME-induced hypertension.
Bunbupha S; Prachaney P; Kukongviriyapan U; Kukongviriyapan V; Welbat JU; Pakdeechote P
Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1189-97. PubMed ID: 26234646
[TBL] [Abstract][Full Text] [Related]
12. Effect of chronic inhibition of nitric oxide on hypertension, insulin resistance, and cardiovascular remodeling in glucose-fed rats.
Pilon M; Wu R; Huot-Marchand JE; deBlois D; Champlain Jd; Couture R
J Cardiovasc Pharmacol; 2009 May; 53(5):405-13. PubMed ID: 19333132
[TBL] [Abstract][Full Text] [Related]
13. Chronic low-dose L-NAME treatment effect on cardiovascular system of borderline hypertensive rats: feedback regulation?
Kopincova J; Puzserova A; Bernatova I
Neuro Endocrinol Lett; 2008 Oct; 29(5):784-9. PubMed ID: 18987608
[TBL] [Abstract][Full Text] [Related]
14. Arbutus unedo prevents cardiovascular and morphological alterations in L-NAME-induced hypertensive rats Part I: cardiovascular and renal hemodynamic effects of Arbutus unedo in L-NAME-induced hypertensive rats.
Afkir S; Nguelefack TB; Aziz M; Zoheir J; Cuisinaud G; Bnouham M; Mekhfi H; Legssyer A; Lahlou S; Ziyyat A
J Ethnopharmacol; 2008 Mar; 116(2):288-95. PubMed ID: 18191352
[TBL] [Abstract][Full Text] [Related]
15. Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor.
Paulis L; Zicha J; Kunes J; Hojna S; Behuliak M; Celec P; Kojsova S; Pechanova O; Simko F
Hypertens Res; 2008 Apr; 31(4):793-803. PubMed ID: 18633192
[TBL] [Abstract][Full Text] [Related]
16. Effect of targeting mitogen-activated protein kinase on cardiac remodeling in rats.
Baraka A; Mikhail M; Guemei A; El Ghotny S
J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):339-46. PubMed ID: 19903984
[TBL] [Abstract][Full Text] [Related]
17. Rosuvastatin attenuates hypertension-induced cardiovascular remodeling without affecting blood pressure in DOCA-salt hypertensive rats.
Loch D; Levick S; Hoey A; Brown L
J Cardiovasc Pharmacol; 2006 Mar; 47(3):396-404. PubMed ID: 16633082
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of BAY 41-2272 (sGC stimulator) on hypertension, heart, and cardiomyocyte hypertrophy induced by chronic L-NAME treatment in rats.
Zanfolin M; Faro R; Araujo EG; Guaraldo AM; Antunes E; De Nucci G
J Cardiovasc Pharmacol; 2006 Mar; 47(3):391-5. PubMed ID: 16633081
[TBL] [Abstract][Full Text] [Related]
19. Protein remodeling of the heart ventricles in hereditary hypertriglyceridemic rat: effect of ACE-inhibition.
Simko F; Pelouch V; Torok J; Luptak I; Matuskova J; Pechanova O; Babal P
J Biomed Sci; 2005; 12(1):103-11. PubMed ID: 15864743
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive effect of rice protein hydrolysate with in vitro angiotensin I-converting enzyme inhibitory activity in spontaneously hypertensive rats.
Li GH; Qu MR; Wan JZ; You JM
Asia Pac J Clin Nutr; 2007; 16 Suppl 1():275-80. PubMed ID: 17392118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
